Inventor
LAPOINTE BLAIR T
US18 patents
Patents
18 patentsUS9657033B2May 23, 2017
Tetrahydronaphthyridine and related bicyclic compounds for inhibition of RORγ activity and the treatment of disease
MERCK SHARP & DOHME20 citations91
US10221146B2Mar 5, 2019
Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease
MERCK SHARP & DOHME6 citations83
US9809561B2Nov 7, 2017
Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease
MERCK SHARP & DOHME8 citations83
US9745265B2Aug 29, 2017
4-heteroaryl substituted benzoic acid compounds as RORgammaT inhibitors and uses thereof
MERCK SHARP & DOHME9 citations83
US9663522B2May 30, 2017
3-aminocycloalkyl compounds as RORgammaT inhibitors and uses thereof
MERCK SHARP & DOHME15 citations83
US9556168B2Jan 31, 2017
N-alkylated indole and indazole compounds as RORgammaT inhibitors and uses thereof
MERCK SHARP & DOHME16 citations83
US9487490B2Nov 8, 2016
3-cyclohexenyl and cyclohexyl substituted indole and indazole compounds as RORgammaT inhibitors and uses thereof
MERCK SHARP & DOHME15 citations83
US10377768B2Aug 13, 2019
Tetrahydronaphthyridine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease
MERCK SHARP & DOHME6 citations82
US9663502B2May 30, 2017
2-Acylamidomethyl and sulfonylamidomethyl benzoxazine carbamates for inhibition of RORgamma activity and the treatment of disease
MERCK SHARP & DOHME12 citations82
US10287272B2May 14, 2019
Substituted indazole compounds as RORgammaT inhibitors and uses thereof
MERCK SHARP & DOHME3 citations72
US10196354B2Feb 5, 2019
4-heteroaryl substituted benzoic acid compounds as RORgammaT inhibitors and uses thereof
MERCK SHARP & DOHME2 citations72
US10221142B2Mar 5, 2019
Substituted pyrazole compounds as RORgammaT inhibitors and uses thereof
MERCK SHARP & DOHME3 citations71
US11161854B2Nov 2, 2021
Indazolyl-spiro[2.2]pentane-carbonitrile derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof
MERCK SHARP & DOHME2 citations68
US10344000B2Jul 9, 2019
Substituted bicyclic pyrazole compounds as RORgammaT inhibitors and uses thereof
MERCK SHARP & DOHME1 citations60
US10745364B2Aug 18, 2020
Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease
MERCK SHARP & DOHME0 citations51
US10689369B2Jun 23, 2020
Substituted indazole compounds as RORgammaT inhibitors and uses thereof
MERCK SHARP & DOHME0 citations51
US10584121B2Mar 10, 2020
Heteroaryl substituted benzoic acids as RORgammaT inhibitors and uses thereof
MERCK SHARP & DOHME0 citations51
US11174248B2Nov 16, 2021
Indazolyl-spiro[2.3]hexane-carbonitrile derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof
MERCK SHARP & DOHME0 citations49